SEC Form D · filed December 8, 2022
Karyopharm Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Deepika R. Pakianathan · Newton, MADirectorChen R. Schor · Newton, MADirectorPeter G. Honig · Newton, MADirectorBarry E. Greene · Newton, MADirectorStuart Poulton · Newton, MAExecMichael Mano · Newton, MAExecReshma Rangwala · Newton, MAExecRichard Paulson · Newton, MAExec · DirectorStephen Mitchener · Newton, MAExecMichael Mason · TORONTO, Ontario, CanadaExecMansoor R. Mirza · Newton, MADirectorGaren G. Bohlin · Newton, MADirectorChristy J. Oliger · Newton, MADirectorSohanya Cheng · Newton, MAExecPeter G. Honig · Newton, MADirectorBarry E. Greene · Newton, MADirectorStuart Poulton · Newton, MAExecMichael Mano · Newton, MAExecReshma Rangwala · Newton, MAExecRichard Paulson · Newton, MAExec · DirectorDeepika R. Pakianathan · Newton, MADirectorChen R. Schor · Newton, MADirectorStephen Mitchener · Newton, MAExecMichael Mason · Marina Del Rey, CAExecMansoor R. Mirza · Newton, MADirectorGaren G. Bohlin · Newton, MADirectorChristy J. Oliger · Newton, MADirectorSohanya Cheng · Newton, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗